The AMA passed a resolution to increase access to anti-obesity medications at its annual House of Delegates meeting.The resolution was championed by the Endocrine Society, according to a press release ...

In patients with moderate peripheral artery disease, use of GLP-1 RAs increases the likelihood of more favorable cardiovascular and major limb outcomes.

Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.

Are meal replacement drinks about weight loss, replacing breakfast, or embracing a new world of personalized smart food?

Real-world results for blockbuster weight-loss meds like Ozempic, Wegovy and Zepbound aren't as impressive as those promised ...

Better therapies for affected individuals are urgently needed. Here we performed the first detailed investigation of the effects of a glucagon like peptide-1 receptor (GLP-1R) agonist in lipoatrophic ...

Are you looking to keep your blood sugar levels in check and feel fuller for longer? Meet GLP-1, your new best friend in the fight against diabetes and weight management. This powerful hormone is ...

Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, dosing and possible side effects in compounded meds. Lifestyle habits—like ...

GLP-1 weight loss medications are helping people make massive life changes, well beyond the numbers on the scale. (Photo illustration: Yahoo News; photos: Getty) ...

Protective associations were seen between GLP-1 RA use and colon and rectal cancers. (HealthDay News) — For adults with diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs ...

ORLANDO — Primary care providers can use a new clinical advisory guideline to nutritionally support patients who are using GLP-1 receptor agonists, according to experts. The joint advisory was ...

GLP-1 receptor agonists are associated with improvements in restrained eating, emotional eating behavior, and QOL. HealthDay News — For patients with overweight/obesity and/or diabetes ...